Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Trial of SU5416 in Combination With Weekly Paclitaxel in Patients With Advanced Malignancies

NCT00006257 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT00006257
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00006257 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Trial of SU5416 in Combination With Weekly Paclitaxel in Patients With Advanced Malignancies
Lead sponsor
City of Hope Medical Center
Phase
Phase 1
Overall status
Completed
Start date
November 30, 2000
Completion date
Not reported
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific